Oral therapy for cholera: amino acids added to electrolyte solutions containing rice or glucose.
Explore the source record for details and available documents.
Amino Acids↗
Biomedical subjects
Richard A Cash
Publications and source records attributed to Richard A Cash.
What is owed to the community before, during and following research: an ethical dialogue.
The paper briefly outlines some of the ethical issues involved in community-based research particularly in developing countries. It focuses on informed consent, confidentially and the obligations to the community or its members who participate in the study. Most ethical guidelines are focused on the individual participants. Yet increasingly the community may be the unit of study. More attention will need to be directed towards developing guidelines for community-based research.
Communication↗
Clinical concerns about reduced-osmolarity oral rehydration solution.
Explore the source record for details and available documents.
Bicarbonates↗
Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
To test the range of beliefs regarding the ethics of testing, in resource poor settings, new therapies that are less efficacious but more affordable and feasible than the best current therapeutic standard.
AIDS Vaccines↗
Formulation of oral rehydration solution.
Explore the source record for details and available documents.
Adult↗
Development of priority vaccines for disease-endemic countries: risk and benefit.
Decisions regarding vaccine regulation and use made by institutions in industrialized countries can have an unintended impact on vaccines' availability in disease-endemic countries. However, regulatory and programmatic decision making by such countries, taking into consideration local risks and benefits, requires adequate resources, both human and financial. Such differing risk-benefit determinations between industrialized and disease-endemic countries will increase product divergence. We propose a single universal standard for risk assessment, based on maximizing net benefit, and an action plan to improve access to priority vaccines through a more robust determination of risk and benefit.
Developing Countries↗